TNFRSF8 and mycosis fungoides: A review by Travaglino et al. noted that CD30-positive cases of transformed MF had less than half the risk of death compared to CD30-negative cases [6]. Imaging tools such as PET-CT are often recommended from stage IIB onward, and targeted biopsies may be necessary to confirm systemic spread [8].